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In recent decades, the world has witnessed unprecedented progress in child survival. How-
ever, our knowledge of what is killing nearly 6 million children annually in low- and middle-
income countries remains poor, partly because of the inadequacy and reduced precision of
the methods currently utilized in these settings to investigate causes of death (CoDs). The
study objective was to validate the use of a minimally invasive autopsy (MIA) approach as
an adequate and more acceptable substitute for the complete diagnostic autopsy (CDA) for
pediatric CoD investigation in a poor setting.
Methods and findings
In this observational study, the validity of the MIA approach in determining the CoD was
assessed in 54 post-neonatal pediatric deaths (age range:1 mo to 15 y) in a referral hospi-
tal of Mozambique by comparing the results of the MIA with those of the CDA. Concordance
in the category of disease obtained by the two methods was evaluated by the Kappa statis-
tic, and the sensitivity, specificity, and positive and negative predictive values of the MIA
diagnoses were calculated.
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A CoD was identified in all cases in the CDA and in 52/54 (96%) of the cases in the MIA,
with infections and malignant tumors accounting for the majority of diagnoses. The MIA cat-
egorization of disease showed a substantial concordance with the CDA categorization
(Kappa = 0.70, 95% CI 0.49–0.92), and sensitivity, specificity, and overall accuracy were
high. The ICD-10 diagnoses were coincident in up to 75% (36/48) of the cases. The MIA
allowed the identification of the specific pathogen deemed responsible for the death in two-
thirds (21/32; 66%) of all deaths of infectious origin. Discrepancies between the MIA and the
CDA in individual diagnoses could be minimized with the addition of some basic clinical
information such as those ascertainable through a verbal autopsy or clinical record. The
main limitation of the analysis is that both the MIA and the CDA include some degree of
expert subjective interpretation.
Conclusions
The MIA showed substantial concordance with CDA for CoD identification in this series of
pediatric deaths in Mozambique. This minimally invasive approach, simpler and more read-
ily acceptable than the more invasive CDA, could provide robust data for CoD surveillance,
especially in resource-limited settings, which could be helpful for guiding child survival strat-
egies in the future.
Author summary
Why was this study done?
• Child mortality has been steadily decreasing globally in the last 25 years, but nearly 6
million child deaths still occur every year, predominantly in low- and middle-income
countries.
• In these settings, current knowledge on the specific causes of child death is jeopardized
by the scarcity of good-quality mortality data.
• Complete diagnostic autopsies, indisputably considered the reference method for cause
of death investigation, are seldom conducted in poor settings, both on account of their
limited acceptability and because of a generalized scarcity of the required pathological
technical expertise.
• We aimed to validate a simpler and potentially much more acceptable minimally inva-
sive autopsy (MIA) approach, by comparing its performance against the complete diag-
nostic autopsy for cause of death investigation in pediatric deaths.
What did the researchers do and find?
• In this study, 54 deaths in Mozambican children <15 years of age were independently
studied using both the MIA method and the full autopsy.
• A comparison of the results of both methods was conducted, and concordance assessed.
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minimally invasive autopsy.
• The MIA approach produced good-quality tissues and bodily fluids for histopatholog-
ical and microbiological investigations.
• The MIA categorization of disease showed substantial concordance with the complete
diagnostic autopsy, and the diagnostic accuracy of the MIA method was also high.
• Coincidence (matching) of the precise ICD-10 diagnosis between the MIA and the full
autopsy was moderate, almost perfect, or perfect in 36/48 of the cases (75%) in which
both methods were concordant for general categorization of disease.
• The MIA approach was particularly accurate in the diagnosis of infectious and oncologi-
cal causes of death, but failed to identify congenital conditions.
• Additionally, the specific microorganisms associated with mortality were readily identi-
fied in the majority of MIA-obtained samples.
What do these findings mean?
• The MIA can identify with significant precision and accuracy the ultimate cause of a
child’s death and even other underlying conditions.
• Due to its less invasive nature, such a method could be more easily utilized in resource-
constrained settings for cause of death investigation and mortality surveillance.
• Reliable estimates of the causes of child mortality can help policy makers design and
implement better and more evidence-based preventive strategies to improve child sur-
vival in high-burden low-income settings.
Introduction
In recent decades, the world has witnessed remarkable and unprecedented progress in terms
of child survival, with child mortality rates halving in the last 25 years, and the annual number
of child deaths dropping from the approximately 12.7 million annual deaths estimated to have
occurred in 1990 to less than 5.9 million in the year 2015 [1]. In spite of these encouraging
trends, the global health community still faces significant challenges in establishing the causes
of these child deaths, particularly for those occurring in low- and middle-income countries,
and is eager to find solutions for the significant uncertainty surrounding estimates and attrib-
utable causes of mortality [2]. Indeed, the construction of models for cause of death (CoD)
estimation has in the past relied, particularly for deaths occurring in poor countries, on data
obtained through death certificates, clinical records, and verbal autopsies, all of which have
shown important weaknesses, including low coverage, poor specificity, and a high possibility
of misclassification errors. This partly explains the major discrepancies found in the different
available estimates of the contribution of different diseases and infections to child mortality
[3,4]. Lack of clarity in this respect is not helping policy makers, who strongly rely on such esti-
mates for local, national, and global health planning and prioritization [5].
High expectations have recently been placed on the development and validation of a mini-
mally invasive autopsy (MIA) tool [6], an approach based on postmortem sampling of key
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organs using needle biopsies. This procedure provides the possibility of a thorough histopatho-
logical and microbiological investigation of the obtained tissues and fluids and, therefore,
more robust and plausible explanations for the CoD than currently utilized non-postmortem
methods. The MIA method was designed as a proxy and eventually potential substitute for the
complete diagnostic autopsy (CDA). The CDA is considered the gold standard method for
CoD ascertainment, but it requires high levels of expertise and infrastructure that are seldom
available in low- and middle-income countries and has little or virtually no acceptability in
these settings. The MIA, which can be conducted relatively rapidly and barely leaves visible
marks, has the potential to be much more acceptable [7], and could be implemented as a sur-
veillance mechanism much more easily than CDA in settings where robust CoD data are
scarce but more needed [8].
The MIA tool was recently validated in a series of studies in Mozambique for adult [9], peri-
natal [10], and maternal deaths. In this validation study, the concordance between the two
methods (MIA and CDA) was high (75.9%), and the MIA reliably recognized infectious dis-
eases and cancers as CoD. Here, we aimed to validate the MIA approach against the CDA in a
post-neonatal pediatric series of deaths.
Methods
This observational study received the approval of the Clinical Research Ethics Committee of
the Hospital Clinic of Barcelona (Spain; File 2013/8677) and the National Bioethics Committee
of Mozambique (Mozambique; Ref. 342/CNBS/13). MIA and CDA procedures were con-
ducted only after verbal informed consent was provided by the relatives.
Study setting and design
The study was conducted at the Department of Pathology of the Maputo Central Hospital, a 1-
500-bed, government-funded quaternary health care center, in collaboration with the Depart-
ment of Pediatrics, which admits children until the age of 15 y.
The STROBE statement and the prospective analysis plan are included as S1 and S2 Text,
respectively. Additional data are available upon request, in accordance with the consortium
agreement signed by the CaDMIA project partnership. Data use and transfer are monitored by
ISGlobal’s Biostatistics and Data Management Unit (contact email: ubioesdm@isglobal.org).
Child deaths that occurred within the hospital from 7 May 2014 to 9 March 2015 were eligi-
ble for inclusion if they fulfilled the following criteria: (1) a CDA requested by the clinician as
part of the medical evaluation of the patient and (2) verbal informed consent to perform the
autopsy given by the relatives. Neonatal deaths (within first 28 d of life) and deaths of trau-
matic origin were excluded. A member of the study staff was tasked with liaising with the fami-
lies in cases of deaths occurring in the pediatric department, but only after the clinicians had
asked for consent for postmortem examination.
Autopsy procedures
Detailed MIA pathological and microbiological methods have been reported elsewhere
[11,12]. The procedure, adapted for pediatric deaths, included an initial disinfection of the
surface of the body, followed by the collection of blood and cerebrospinal fluid (CSF), using
pediatric needles and aiming to collect ~10–15 ml of each fluid. In young infants, a lumbar
puncture was attempted first in order to obtain CSF. If unsuccessful, CSF was obtained by
occipital puncture, reaching the cisterna magna, as in adults. The MIA procedure also included
the puncture of solid organs (liver, lungs, and central nervous system [CNS]) (using biopsy
needles, 14G–16G) and bone marrow (using a trephine needle) for microbiological and
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pathological analysis. In addition, heart, spleen, and kidneys were sampled (using biopsy nee-
dles, 14G–16G) for pathology examination. Immediately after the MIA, the CDA procedure
was conducted by a second pathologist not involved with the MIA and following a standard-
ized protocol for pediatric autopsies [13]. Histological and microbiological analyses were con-
ducted on samples from the same viscera collected in the MIA and from any grossly identified
lesions. The microbiological results for the blood and CSF were also included in the CDA
evaluation.
Histological and microbiological analyses
A team of two pathologists and two microbiologists reviewed and analyzed the samples from
the MIA, blind to any clinical information and before the analysis of the CDA samples and
revision of the autopsy’s macroscopic findings report, which provides information about the
findings during the autopsy process, at both the body and organ level (e.g., malformations,
internal hemorrhages, tumors). The histological evaluation included staining with hematoxy-
lin and eosin in all samples and additional histochemical and/or immunohistochemical stains
(e.g., Ziehl—Neelsen and cytomegalovirus) whenever needed to reach a diagnosis. Microbio-
logical methods have been reported in detail elsewhere [12]. In all recruited cases, investigation
for highly incident pediatric pathogens was conducted. This included screening for Plasmo-
dium falciparum by real-time PCR [14,15]; detection of antibodies against human immunode-
ficiency virus (HIV)–1/2 and against hepatitis C virus; detection of hepatitis B surface antigen;
multiplexed PCR analyses for most common respiratory viruses (e.g., respiratory syncytial
virus and adenovirus) and bacteria (e.g., Streptococcus pneumoniae, Haemophilus influenzae,
Neisseria meningitidis); culture of organisms (bacterial and fungal) using samples from blood,
CSF, liver, lungs, and CNS; and, in some cases, further investigation of bacterial or fungal pres-
ence using 16S rRNA gene PCR [16] or 18S rDNA—ITS PCR, respectively. All the sequencing
reactions for amplicons obtained by either 16S rRNA or 18S rDNA—ITS PCR were performed
by the Sanger method at the sequencing platform of the Hospital Clinic of Barcelona. Identifi-
cation was performed by comparing the sequences obtained with those present in GenBank,
using the BLAST algorithm (http://blast.ncbi.nlm.nih.gov/Blast.cgi). HIV viral load was deter-
mined in samples positive for antibodies against HIV-1/2, and for patients confirmed to be
HIV-infected, an additional microbiological screening was conducted that included real-time
PCR in CSF and CNS samples for Toxoplasma gondii, Mycobacterium tuberculosis, and Crypto-
coccus spp. and real-time PCR in lung samples for Pneumocystis jirovecii, Cryptococcus spp.,
and M. tuberculosis. Other microorganisms were further investigated depending on the patho-
logical findings observed in the MIA-obtained tissues.
After a washout period (minimum 3 mo, range 3–6 mo), the same team analyzed the sam-
ples of the CDA following the same approach used for the analysis of the MIA samples, with
the only exception that tissues obtained during CDA were not routinely cultured, and only
molecular methods were used to investigate pathogens.
As previously described elsewhere [9], two scales were developed to grade the strength of
the evidence of the findings, one based on the severity of the pathological findings and the
other on the distribution and type of the microorganisms identified (Table 1).
Using a combination of the strength of the evidence of the pathological and the microbio-
logical findings, a category was assigned to the certainty of the CoD attribution of the MIA
diagnosis and the CDA diagnosis. These categories included no diagnosis and diagnosis of
low, moderate, high, and very high certainty (Table 2). In the CDA evaluation, the clinical data
were used to provide guidance and/or evidence on CoD in cases with no diagnosis or with
pathological/microbiological diagnoses of low or moderate certainty.
Validity of MIA in child deaths
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Determination of the cause of death
Once all the analyses of the MIA samples had been completed, a panel composed of a patholo-
gist, a microbiologist, and a pediatrician with expertise in infectious diseases and epidemiology
evaluated all the data of the MIA and assigned the putative MIA diagnosis. Details of the meth-
odology for CoD determination have been described elsewhere [9]. Briefly, the findings
obtained in the MIA sampling were used to assign the MIA diagnosis, i.e., the main condition
putatively leading to death. No clinical information was used for the MIA diagnosis assign-
ment. Whenever detected, a chain of conditions (up to four) was established for the most prob-
able chronological sequence of events leading to death [17]. Fundamental diseases potentially
contributing to the death were classified as underlying conditions (e.g., HIV infection or mal-
nutrition). In all cases, the direct CoD and not the underlying disease was considered as the
main CoD (e.g., bacterial pneumonia in a toddler with malnutrition, or lymphoma in an HIV-
Table 1. Strength of the evidence of the autopsy findings in the complete diagnostic autopsy and the minimally invasive autopsy.
Level Evidence Pathological findingsa Microbiological findingsb
0 None No pathological findings, or nonspecific
changes
No microorganisms identified
1 Slight Mild pathological findings, unlikely to be the
cause of death
Microorganisms that are frequent contaminants
2 Fair Mild pathological findings, possibly causing
deathc
Microorganisms that can represent true pathogens or colonization/contaminants; mixed
infectionsd
3 Moderate Pathological findings of moderate intensity,
probably causing deathc
Microorganisms that can represent either true pathogens or colonization/contaminants
detected by both molecular and culture-based methods
4 Strong Severe pathological findings likely to be the
cause of death
Microorganisms that represent true pathogens and/or microorganisms consistently
detected in4 samples
aPathological findings include only microscopic changes in the minimally invasive autopsy and both macro- and microscopic changes in the complete
diagnostic autopsy.
bMicrobiology examples according to strength of evidence classification: (1) coagulase-negative staphylococci, group viridans streptococci; (2 and 3)
Enterobacteriaceae bacteria such as Klebsiella pneumoniae or Escherichia coli, non-fermentative gram-negative bacilli, adenovirus, parainfluenza virus; (4)
S. pneumoniae, H. influenzae, Cryptococcus spp., T. gondii, M. tuberculosis, P. jirovecii.
cThe finding in the histological (histochemistry or immunohistochemistry) exam of a microorganism associated with inflammatory changes increased the
pathological score by one.
dMixed infection: multiple pathogens are detected, and it is not possible to determine which one represents the etiological cause of death.
https://doi.org/10.1371/journal.pmed.1002317.t001
Table 2. Level of certainty of the diagnosis of cause of death obtained by combination of the strength of the evidence of the pathological and
microbiological findings.
Pathology Microbiology
0 1 2 3 4
N Y N Y N Y N Y
0* No diagnosis* No diagnosis* No diagnosis* Low* Moderate*
1 Low Low Low Low Low Moderate Moderate Moderate Moderate
2 Low Low Low Low Moderate Moderate Moderate Moderate High
3 Moderate Moderate Moderate Moderate High High High High Very High
4 High High High High High High Very High Very High Very High
N: the microorganisms identified are rarely associated with the histological lesions observed; Y: the microorganisms identified are in concordance with the
histological lesions observed.
*When the level of evidence for the pathology findings is zero, N and Y are not applicable.
https://doi.org/10.1371/journal.pmed.1002317.t002
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infected child). Finally, other conditions or concomitant infections contributing to death
but not related to the chain of events leading to death were considered as other significant
conditions.
The same team evaluated the data from the CDA and assigned the final CDA diagnosis of
CoD using the same methodology. The CDA diagnosis integrated all the findings from the
macroscopic, histological, and microbiological analysis together with the clinical information
and was considered the “gold standard” diagnosis.
All morbid conditions directly leading to death, any underlying conditions (if present), as
well as any other significant conditions possibly contributing to death were codified following
the International Classification of Diseases, Tenth Revision (ICD-10) [18]. This codification
process was conducted independently for the MIA and the CDA diagnoses. The CoDs were
classified into five major categories of diseases: (1) infectious diseases, (2) malignant tumors,
(3) congenital malformations, (4) other diseases (including noninfectious cardiovascular or
pulmonary diseases), and (5) nonconclusive.
Statistical methods
In the original protocol, a sample size calculation was performed according to the expected
prevalence of infectious diseases causing death in all age groups. A minimum sample size was
not calculated to assess the concordance between MIA and CDA for all categories of disease in
this particular age group. Instead, we used cases available that met our study sample criteria.
The concordance between the MIA diagnosis and the gold standard CDA diagnosis in
terms of major category of disease was assessed by the Kappa statistic and was interpreted as
suggested by Landis and Koch [19]. The diagnostic accuracy of the MIA, i.e., its ability to iden-
tify the categories established by the gold standard CDA diagnosis, was evaluated via sensitiv-
ity, specificity, positive and negative predictive values, and total percentage of cases correctly
classified.
Additionally, the coincidence of ICD-10 codes between the MIA and the CDA was assessed
for each individual case to determine, in those cases where disease categorization was concor-
dant between both methods, to what degree the MIA’s attributed CoD diagnosis coincided
with that of the gold standard. The ICD-10 system classifies diagnoses into nested classes,
where diseases and conditions are organized in chapters, blocks, and four-character categories
[17,18]. Thus, coincidence was classified as perfect when the ICD-10 codes were identical in
chapter, block, and four-character category between the MIA and CDA diagnosis [17], and
“almost perfect” when ICD-10 codes coincided up to the first three characters of the category.
Coincidence was classified as moderate when the codes were within the same chapter and
block, but there was a discrepancy in the first three characters of the category. Coincidence
was classified as low when the codes were within the same chapter, but there was a discrepancy
in the block and in the first three characters of the category. Finally, when the MIA and the
CDA diagnoses were in a different chapter, the coincidence in diagnosis was classified as
“none.”
Statistical analyses were performed using Stata version 14.1 (StataCorp, College Station,
Texas, US). The analytical plan was determined once all the histological and microbiological
results became available.
Results
Coupled MIA and CDA procedures were performed in 54 children (37 males [69%] and 17
females [32%]). Mean age was 5.6 y (range:1 mo–15 y), with 14/54 (26%) being infants, and
17/54 (32%) being between 12 and 59 mo of age. The interval between death and the beginning
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of postmortem procedures ranged between 4 and 56 h, with 19/54 (35%) procedures being
conducted after 24 h, of which 2/54 (4%) were performed over 48 h after the time of death. All
CDAs were conducted within 30 min after completing the MIA. Blood was successfully
obtained in 54/54 (100%) of the cases, with a mean volume of 18.3 ml (standard deviation 3.1
ml), and CSF was obtained in 53/54 (98%) of the cases. Liver and CNS were successfully
obtained by MIA puncture in 100% of the cases, and lung in 53/54 (98%) of the cases. Lower
rates of success were obtained for kidney, heart, and spleen. In addition to the targeted organs,
gastrointestinal tract, adrenal glands, pancreas, and other organs, although not deliberately tar-
geted, were also often sampled as part of the routine thoracic and abdominal punctures. Fig 1
Fig 1. Performance of the minimally invasive autopsy method in terms of successful sampling of each targeted tissue/organ in
the 54 studied pediatric cases. CNS, central nervous system.
https://doi.org/10.1371/journal.pmed.1002317.g001
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summarizes the performance of the MIA method in terms of successful sampling of each tar-
geted tissue/organ in the 54 studied cases.
Minimally invasive autopsy and complete diagnostic autopsy diagnoses
A final CoD was identified in the CDA in 100% (54/54) of the cases: 44/54 (82%) with high
or very high certainty, 7/54 (13%) with moderate certainty, and 3/54 (6%) with low certainty.
Infections accounted for 78% of the deaths (42/54), malignant tumors for 13% (7/54), con-
genital malformations for 4% (2/54), and other diseases for 6% (3/54, including one case
each of heart failure, acute interstitial pneumonia, and cerebral hemorrhage). Within the
category of infectious diseases, disseminated infections (including sepsis of different etiolo-
gies and miliary tuberculosis), accounted for 16/42 cases, followed by pulmonary infections
(13/42) and CNS infections (8/42). Within the category of malignant tumors, three of the
seven cases were Burkitt lymphoma and two were Ewing sarcoma/primitive neuroectoder-
mal tumors.
A CoD was identified in the MIA in 52/54 (96%) of the cases: 37/52 (71%) with high or very
high certainty, 11/52 (21%) with moderate certainty, and 4/52 (8%) with low certainty. Infec-
tions accounted for 42/54 (78%) of the deaths, malignant tumors for 7/54 (13%), other diseases
for 3/54 (6%), and in two cases (4%) the MIA diagnosis was nonconclusive. S1 Table summa-
rizes the CoD for each individual according to the MIA and the CDA.
Concordance in the categorization of disease between the minimally
invasive autopsy diagnosis and the complete diagnostic autopsy
diagnosis
Table 3 shows the concordance of the categorization of the CoD established by the MIA and
the CDA (gold standard). The MIA categorization of disease showed substantial concordance
with the CDA categorization (Kappa = 0.70, 95% CI 0.49–0.92) and agreed in 48/54 (89%) of
the cases. Concordance in the infectious disease (39/42; 93%) and malignant tumor (7/7;
100%) categories was high, while the MIA did not agree with the CDA in the two cases of con-
genital malformations (0/2) and agreed in only one of the three cases classified in the “other
diseases” category (33%).
Table 3. Concordance of the categorization of the cause of death established by the minimally invasive autopsy and the complete diagnostic
autopsy (gold standard).
MIA diagnosis CDA diagnosis (gold standard)
Infectious diseases Malignant tumors Congenital malformations Other diseases Nonconclusive Total
Infectious diseases 39 0 2 1 0 42 (78%)
Malignant tumors 0 7 0 0 0 7 (13%)
Congenital malformations 0 0 0 0 0 0 (0%)
Other diseases 1 0 0 2 0 3 (6%)
Nonconclusive 2 0 0 0 0 2 (4%)
Total 42 (78%) 7 (13%) 2 (4%) 3 (6%) 0 (0%) 54 (100%)
Kappa: 0.70 (standard error 0.0956; 95% CI 0.49–0.92), which is considered substantial concordance. The numbers in bold represent the concordant cases
between both methods.
CDA, complete diagnostic autopsy; MIA, minimally invasive autopsy.
https://doi.org/10.1371/journal.pmed.1002317.t003
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Coincidence of ICD-10 codes between the minimally invasive autopsy
and the complete diagnostic autopsy for identification of the cause of
death
For the 48 cases in which no discrepancy was found in categorization of disease between the
MIA and the CDA, we performed an additional analysis to evaluate the degree of coincidence
of ICD-10 codes (from perfect to none) between the two methods. Table 4 summarizes the
coincidence spectrum regarding ICD-10 coding, according to disease category. The coinci-
dence level was generally good, with 36 of the 48 cases (75%) showing a perfect, almost perfect,
or moderate coincidence.
In children dying from infectious diseases, the CDA detected a plausible microorganism to
cause the infection in 32/42 (76%) cases. The MIA detected and assigned the same etiological
agent in 21/32 (66%) of these cases. Table 5 shows the list of etiological agents identified in the
CDA and MIA, and in which number of cases the same etiological agent was identified for the
same CoD diagnosis. As an example, disseminated infection due to gram-negative bacteria
was diagnosed in five CDA cases and in five MIA cases, but only in three cases did the diagno-
ses match for both autopsy methods.
Accuracy of the minimally invasive autopsy
Table 6 shows the sensitivity, specificity, and the positive and negative predictive values of the
MIA diagnosis for the major CoD categories, as well as the percentage of cases correctly classi-
fied (accuracy) by the MIA. Sensitivity of the MIA method was high for infectious diseases and
malignant tumors, and low or very low for the other categories. Overall accuracy remained
high (>89%) for all disease categories.
Underlying conditions and concomitant infections
Antibodies against HIV were detected in 17/54 (32%) of the deaths. HIV-1 RNA was detectable
in all 17 cases (100%), with viral loads ranging from 463 up to 10,000,000 copies/ml. HIV was
considered in all cases as the underlying, but not the direct, CoD. Five cases (9%) had hepatitis
B surface antigen antibodies, and one (2%) had antibodies against hepatitis C. P. falciparum
Table 4. Summary of ICD-10 code coincidence for the 48 cases for which disease categorization did not show discrepancy between the minimally
invasive autopsy and the complete diagnostic autopsy diagnosis.
Disease category (concordant cases) Coincidence in diagnosis (MIA versus CDA)
Perfect or almost perfect Moderate Low None
n Percent (95% CI) n Percent (95% CI) n Percent (95% CI) n Percent (95% CI)
Overall (n = 48) 32 66.7 (45.0–72.4) 4 8.3 (2.1–17.9) 3 6.3 (1.2–15.4) 9* 18.8 (7.9–29.3)
Infectious diseases (n = 39) 24 61.5 (30.9–58.6) 3 7.7 (1.2–15.4) 3 7.7 (1.2–15.4) 9 23.1 (7.9–29.3)
Malignant tumors (n = 7) 7 100.0 (5.4–24.9) 0 0 (0–6.6)† 0 0 (0–6.6)† 0 0 (0–6.6)†
Other diseases (n = 2) 1 50.0 (0.1–9.9) 1 50.0 (0.1–9.9) 0 0 (0–6.6)† 0 0 (0–6.6)†
*The nine cases in which ICD-10 code coincidence was categorized as “none” involved the following pairs of discordant ICD-10 chapter ascertainments: (1)
CDA: other bacterial diseases; MIA: influenza and pneumonia; (2) CDA: other bacterial diseases; MIA: influenza and pneumonia; (3) CDA: other bacterial
diseases; MIA: influenza and pneumonia; (4) CDA: viral infections of the central nervous system; MIA: influenza and pneumonia; (5) CDA: influenza and
pneumonia; MIA: other bacterial diseases; (6) CDA: diseases of peritoneum; MIA: influenza and pneumonia; (7) CDA: diseases of peritoneum; MIA:
influenza and pneumonia; (8) CDA: diseases of peritoneum; MIA: other bacterial diseases; (9) CDA: renal tubule-interstitial diseases; MIA: influenza and
pneumonia.
†One-sided 97.5% confidence interval.
CDA, complete diagnostic autopsy; MIA, minimally invasive autopsy.
https://doi.org/10.1371/journal.pmed.1002317.t004
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infections were detected by real-time PCR in 4/54 (7%) of the children, but only two patients
were deemed to have died from malaria, according to the pathology findings. Additionally, five
patients had histological evidence of past malarial infection (diagnosed by the identification of
malarial pigment in the liver without blood parasitemia): two of them had Burkitt lymphoma
as CoD. Respiratory viruses such as parainfluenza, influenza, adenovirus, and rhinovirus were
Table 5. List of etiological agents identified in the complete diagnostic autopsy and the number of
the same identical agents identified in the minimally invasive autopsy, classified by disease category.
Disease category and etiological agent CDA (gold standard) MIA MIA and CDA
Disseminated infections 17 17 8
Gram-negative bacteria 5* 5† 3
Streptococcus pneumoniae 3 3 2
Mycobacterium tuberculosis 3 1 1
Cytomegalovirus 2 2 1
Plasmodium falciparum 2 1 1
Haemophilus influenzae 1 0 0
Tetanus‡ 1 0 0
Salmonella enterica 0 2 0
Tropheryma whipplei 0 1 0
No agent 0 2 0
Pulmonary infections 13 20 11
Cytomegalovirus 3 3 3
Streptococcus pneumoniae 3 6 3
Pneumocystis jirovecii 2 2 2
Adenovirus 1 1 1
Klebsiella pneumoniae 1 2 0
Escherichia coli 0 1 0
Haemophilus influenzae 0 1 0
Mycobacterium tuberculosis 0 1 0
No agent 3 3 2
Central nervous system infections 8 5 3
Streptococcus pneumoniae 2 3 2
Rabies virus 2 0 0
Cryptococcus sp. 1 1 1
Acinetobacter baumannii 0 1 0
No agent 3 0 0
Other infections 4 0 0
Klebsiella pneumoniae§ 1 0 0
No agentk 3 0 0
Total 42 42 22
*Two cases of Pseudomonas aeruginosa, two cases of E. coli, and one case of Aeromonas jandaei.
†One case of A. jandaei, one case of Ps. aeruginosa, one case of E. coli, one case of K. pneumoniae, and
one case of mixed Gram-negative infection.
‡Tetanus diagnosed by the combination of clinical information and histology findings without microbiological
confirmation of the microorganism.
§One case of peritonitis.
kTwo cases of peritonitis and one case of pyelonephritis.
CDA, complete diagnostic autopsy; MIA, minimally invasive autopsy.
https://doi.org/10.1371/journal.pmed.1002317.t005
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identified in 14/54 cases (26%). However, adenovirus was the only virus recognized as the
plausible etiological agent of a pneumonia that was considered the CoD.
Discussion
This study shows, to our knowledge for the first time, the validity of a simplified MIA
approach, when compared to the gold standard method (CDA plus clinical information), for
CoD investigation in pediatric deaths. This validation study shows a substantial degree of con-
cordance (89%; Kappa value of 0.70) between the MIA and the CDA diagnoses in a series of 54
children who died at the referral quaternary hospital in Maputo, Mozambique.
Although the study was designed exclusively to validate a methodology (the MIA) and not
to comprehensively describe the etiologies responsible for child death in such a setting, it also
provides a glimpse of CoD distribution, with infectious diseases accounting for over three-
quarters of all deaths, of which bacterial infections and immunosuppression-derived complica-
tions were the most frequently detected. In this respect, our results highlight the brutal impact
of the HIV pandemic, blatantly patent for the past decade in Mozambique, as HIV co-infection
was confirmed in nearly 28% of all patients.
Malaria—not expected to be a major contributor to mortality in this urban setting, where
transmission intensity is among the lowest in the country [20]—was directly responsible for
two deaths (4%) and was found as an associated condition in two additional cases. Impor-
tantly, nine (17%) of the studied children were confirmed to have died of invasive bacterial
infections (sepsis, meningitis, or pneumonia) secondary to either S. pneumoniae or H. influen-
zae type b, two pathogens for which vaccination with conjugate vaccines was already being
implemented during the study period as part of the Mozambican Expanded Programme on
Immunization.
When assessing the discrepancies observed between the MIA and the CDA diagnoses, it
seems apparent that the MIA performs well in the detection of pediatric infections and can-
cers, both when these are disseminated and—although to a lesser extent—when they are more
localized. Pulmonary infections only affecting a specific lobe may be missed if the sampling of
the lungs does not involve multiple punctures from both sides. However, in this series only
one of the 13 pulmonary infections (8%) was missed, in comparison to the higher proportion
(29%) of episodes missed in the adult MIA validation series [9]. Similarly, CNS infections pref-
erentially affecting the occipital and/or brain stem regions may be missed with the current
MIA protocol, which uses a transethmoidal approach [11]. However, although infections such
as rabies preferentially localize to the brain stem [21], we were able to retrospectively confirm
Table 6. Sensitivity, specificity, positive and negative predictive values, and accuracy of the minimally invasive autopsy for the different cause of
death categories in children.
Cause of death
category
Number of Cases Sensitivity Specificity Positive predictive value Negative predictive value Correctly classified
Infectious diseases 42 93 (81, 99) 75 (43, 95) 93 (81, 99) 75 (43, 95) 89 (77, 96)




100 (59,100) 100 (92,100) 100 (93,100)
Congenital malformations 2 0 (0,84) 100
(93,100)
N/A 96 (87,100) 96 (87,100)
Other diseases 3 67 (9,99) 98 (90,100) 67 (9,99) 98 (90,100) 96 (87,100)
Nonconclusive 0 N/A 96 (87,100) 0 (0,84) 100 (93,100) 96 (87,100)
Data given as percentage (95% confidence interval).
N/A, not applicable.
https://doi.org/10.1371/journal.pmed.1002317.t006
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the presence of the virus in tissues obtained with the MIA in two cases in which the diagnosis
was originally missed. In children, the often more rapid dissemination of initially localized
infections [22,23], in comparison to adults, may prove a comparative advantage in terms of
infection detectability with a method such as the MIA, in addition to the fact that, due to the
smaller surface area of children, the MIA obtains proportionately larger samples of the organs.
Importantly, none of the 54 studied child deaths were attributed to diarrheal diseases by the
MIA or CDA, even though diarrheal disease still accounts for 9% of all deaths in children
under 5 y of age (558,000 per year) [24], and up to a fourth of the patients (14/54) were admit-
ted with this symptom in the clinical episode that led to their death. A more systematic patho-
gen screening of stools, and targeted bowel mucosa biopsies, could be included in the MIA
sampling standard operating procedure in order to improve these results. However, further
studies are necessary to evaluate the usefulness of stool analysis in postmortem studies. Other
important infections that were also missed by the MIA were those of abdominal origin (perito-
nitis), which in the absence of specifically targeted sampling may be challenging to unveil. The
same proposed additions to investigate diarrheal deaths may contribute to improving the
detection of abdominal infections by the MIA.
The MIA also missed two types of lethal infections—rabies (two cases) and tetanus (one
case)—that appear challenging to ascertain in the absence of any clinical history. As the study
aimed to validate the MIA method without any additional clinical information against the
gold standard (CDA, including clinical data), it would have been impossible to ascertain such
diseases through the limited tissue samples of the MIA in the absence of clear pathognomonic
pathological changes. The CDA procedure, which included a summary of the premortem clin-
ical information, was able to confirm such infections after the suspicion was raised by the clini-
cal history. Once the MIA—CDA comparison had been done, rabies and tetanus were also
identified in the MIA samples, proving the value of including these pathogens in the MIA diag-
nostic screening panel. Our purist approach of validation is needed for understanding the per-
formance of the method per se, but it is likely that in the future, should this methodology be
implemented, the clinical history—or, in its absence, data from the verbal autopsy—may con-
tribute to the overall diagnosis, if available.
The MIA performed poorly for the detection of congenital malformations (two cardiac
malformations) and other noninfectious conditions. The blind sampling scheme of the MIA
protocol does not allow the macroscopic observation that becomes possible as part of the
CDA, and complementary methods will need to be devised if conditions affecting cardiac mor-
phology and functionality are to be adequately detected through noninvasive postmortem
approaches.
A third of the MIAs conducted in the study failed to start within 24 h after death, as pro-
posed in the protocol. The study team accepted these protocol violations in the understanding
that data provided in these cases could also be informative for future implementation of the
MIA tool for surveillance purposes. Indeed, in a country such as Mozambique, a paradigmatic
example of a low-income setting, over 50% of child deaths occur at home [25] and are not nec-
essarily notified or detected. If the MIA tool has been designed for use not only at the health
system level but also at the community level, it will need to demonstrate that performance
does not significantly decay beyond the first 24 h after death, assuming that in many cases it
may be extremely challenging to reach the deceased children in the first 24 h. An increased
detection of bacteria such as those belonging to the family Enterobacteriaceae or the genus
Pseudomonas, traditionally associated with the usual microbiome in forensic samples and usu-
ally reaching a higher percentage of recovery between the third and fifth postmortem days
[26], would be foreseen if samples are affected by the time difference between death and MIA
performance. In our study, only 13% (7/54) of the CoDs were attributed to an infectious agent
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belonging to one of these bacterial groups; in six out of seven of those cases, the necropsy had
been performed within the first 24 h after death. In any case, more data are needed on the per-
formance decay of MIAs after the first 24 h after death, before widening the time window in
which MIA can be recommended, particularly if no refrigeration of the corpse is available.
Although the value of the MIA for CoD investigation in more ill-defined diseases such as
malnutrition and anemia still needs to be determined, we have shown the potential of this
approach to substitute for the CDA for CoD investigation in adults [9], children, and neonates
and stillborn infants [10]. However, the MIA sampling technique does not bypass many of the
challenges that CoD investigation faces in low- and middle-income countries, including the
need for trained technicians, facilities for performance of the procedure, adequately run histol-
ogy laboratories, high-quality clinical laboratory support, pathology expertise in histological
interpretation, and, finally, interdisciplinary collaboration to determine the most likely CoD.
Additionally, the MIA could remain a futile advance unless its acceptability and feasibility is
shown to be superior to that of the CDA. We have shown that the willingness to know the
CoD and hypothetical acceptability of the use of such a tool is high (>75%) at five sites in sub-
Saharan Africa and Asia that vary in their geographic, religious, and socio-cultural features [7].
This is a pivotal finding for the MIA’s future implementation as a tool for CoD surveillance,
but further socio-behavioral research and guidance are warranted prior to real-life implemen-
tation, particularly in rural settings. The widespread and routine implementation of the MIA
for CoD surveillance remains, for the moment, quixotic, but this approach could be progres-
sively deployed in sentinel sites, and as a complement to already existing—albeit imperfect—
methods, such as the verbal autopsy [27]. However, a methodology like this one, utilizing such
a panoply of different microbiological tests and highly specialized histopathological proce-
dures, is probably unpractical outside of research contexts. Its wider implementation for CoD
surveillance purposes in those settings where child mortality remains high, but where diagnos-
tic tools are scarce, will require a future simplification of the procedure, its linkage with
cheaper point-of-care screening methodologies, and a significant investment in local pathol-
ogy and microbiology capacity building.
The scaling up of such simplified postmortem methods could then provide robust and cred-
ible information from settings where mortality data are patchy or nonexistent, and in turn
help refine the rusty estimation models and methods that are routinely utilized to construct
CoD global estimates, and which too often have been questioned. The strengthening of data
sources would finally result in a more evidence-based public health policy, necessary for con-
tinuing progress in the resolution of the global inequities that hamper child survival.
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